US HB6101 | 2021-2022 | 117th Congress
Status
Spectrum: Moderate Partisan Bill (Republican 4-1)
Status: Introduced on December 1 2021 - 25% progression, died in committee
Action: 2021-12-02 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 1 2021 - 25% progression, died in committee
Action: 2021-12-02 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program.
Title
Drug Price Transparency in Medicaid Act of 2021
Sponsors
| Rep. Earl Carter [R-GA] | Rep. Vicente Gonzalez [D-TX] | Rep. Jerry Carl [R-AL] | Rep. Christopher Jacobs [R-NY] |
| Rep. Dan Meuser [R-PA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2021-12-02 | House | Referred to the Subcommittee on Health. |
| 2021-12-01 | House | Referred to the House Committee on Energy and Commerce. |
| 2021-12-01 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/6101/all-info |
| Text | https://www.congress.gov/117/bills/hr6101/BILLS-117hr6101ih.pdf |
